A comparison of the potential of Clinical Trials Centers within both public and commercial trial facilities
References
- Industry Clinical Trials in Poland Possibilities to increase number and scope of trials in Poland. Infarma; 2021. [https://www.infarma.pl/assets/files/2022/CT_REPORT_in_PL_PL.pdf.]
- Sedrak MS, Freedman RA, Cohen HA, Muss HB, Jatai A, Klepin HD, et al. Older adult participation in cancer clinical trials: A systematic review of barriers and interventions. CA: Cancer J Clin. 2021;71(1):78-92.
- Adams A, Adelfio A, Barnes B, Berlien R, Branco D, Coogan A, et al. Risk-based monitoring in clinical trials: 2021 update. Ther Innov Regul Sci. 2023;57(3):529-37.
- Miyazaki K, Saito H. Sponsors’ experiences with site management organizations in Japan. Ther Innov Regul Sci. 2013;36(4):763-8.
- Tańska E. Selected aspects of conducting clinical trials in Poland from the perspective of an oncology center (review paper). Uniwersytet Wrocławski; 2021:371-88.
- Wolf JA, Marshburn D, Lavela SL. Defining patient experience. PXJ. 2014;1(1):7-19.
- Peng Z, Wang J, Xu X, Wan C, Chen Y. Awareness of clinical research coordinators toward ethics and protection of clinical trial patients. TIRS. 2023;57(3):561-9.
Language: English
Page range: 19 - 25
Submitted on: Jan 2, 2023
Accepted on: Mar 19, 2023
Published online: Apr 11, 2024
Published in print: Mar 1, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Related subjects:
© 2024 Marlena Huskowska-Strozek, Michal Wos, Anna Kominek, Katarzyna Drop, Katarzyna Skorka, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.